Free preview

Alpha-Thalassemia

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Alpha-thalassemia is a genetic blood disorder that affects the body's ability to produce enough healthy red blood cells. It involves the blood system, specifically the production of hemoglobin, which carries oxygen throughout the body. People with this condition have a reduced amount or absence of alpha-globin chains, a key part of hemoglobin. This leads to anemia, causing symptoms like fatigue, weakness, and pale skin. The severity of symptoms depends on how many alpha-globin genes are affected. In severe cases, it can cause serious health problems before or shortly after birth. Understanding this condition helps explain why some people have chronic anemia and related complications.

Clinical Definition

Alpha-thalassemia is reduced alpha-globin synthesis, usually from HBA1/HBA2 deletions and sometimes nondeletional variants. The spectrum includes an asymptomatic carrier state, microcytic trait, HbH disease (β4) with variable hemolytic anemia, and Hb Bart syndrome (γ4) with severe fetal anemia and hydrops. Untreated Hb Bart syndrome is usually fatal before or shortly after birth; intrauterine transfusions and specialized postnatal care can permit survival. Severity depends on genotype and residual alpha production.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses